[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369211-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369211-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mesenchymal-stem-cells-modulate-breast-cancer-progression-through-their-secretome-by-downregulating-ten-eleven-translocation-1-research-findings-on-tet1-inhibition","Mesenchymal stem cells modulate breast cancer progression through their secretome by downregulating ten-eleven translocation 1 - Research Findings on TET1 Inhibition","","Mesenchymal stem cells (MSCs) shape the tumor microenvironment via their paracrine secretome, which can influence breast cancer behavior in opposing ways depending on context. This study evaluates MSC-derived secretome effects on breast cancer cells, identifying ten-eleven translocation 1 (TET1) as a key DNA demethylase target in triple-negative breast cancer (TNBC). MSC secretome inhibits proliferation and migration and promotes epithelial marker shifts, while TET1 is elevated in TNBC tissues. MSC secretome and TET1 silencing both downregulate TET1, inducing cell cycle arrest, enhanced apoptosis, and increased cisplatin sensitivity, supporting a cell-free therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mesenchymal-stem-cells-modulate-breast-cancer-progression-through-their-secretome-by-downregulating-ten-eleven-translocation-1-research-findings-on-tet1-inhibition/369211/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mesenchymal-stem-cells-modulate-breast-cancer-progression-through-their-secretome-by-downregulating-ten-eleven-translocation-1-research-findings-on-tet1-inhibition/369211.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the MSC-derived secretome affect breast cancer cell growth and movement?","Question",{"text":63,"@type":64},"Treatment with MSC-derived secretome significantly inhibits proliferation and migration of MDA-MB-231 and MCF-7 breast cancer cell lines, reducing viability and migration rates versus control cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular changes indicate inhibition of epithelial-to-mesenchymal transition?",{"text":68,"@type":64},"Western blot analyses show downregulation of Cyclin D1 and c-Myc, decreased N-cadherin, and increased E-cadherin, consistent with potential suppression of epithelial-to-mesenchymal transition.",{"name":70,"@type":61,"acceptedAnswer":71},"How is TET1 linked to chemoresistance and how do researchers test it?",{"text":72,"@type":64},"TET1 is upregulated in TNBC tissues, and MSC-derived secretome downregulates TET1 in breast cancer cells. Silencing TET1 with siRNAs causes cell cycle arrest and enhanced apoptosis and increases MDA-MB-231 sensitivity to cisplatin, indicating a role in chemoresistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369211,1790798605,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMesenchymal stem cells modulate breast cancer progression through their secretome by downregulating ten-eleven translocation 1  \nRomina Motamed1,3, Keyvan Jabbari1,3, Mahboubeh Sheikhbahaei1, Mohammad H. Ghazimoradi1, Sara Ghodsi1, Motahareh Jahangir1, Neda Habibi2 & Sadegh Babashah1􀀍  \nMesenchymal stem cells (MSCs) have emerged as crucial players within the tumor microenvironment (TME), contributing through their paracrine secretome. Depending on the context, the MSC-derived secretome can either support or inhibit tumor growth. This study investigates the role of MSC-derived secretome in modulating breast cancer (BC) cell behavior, with a focus on ten-eleven translocation 1 (TET1), a DNA demethylase with known oncogenic properties in triple-negative breast cancer (TNBC) . We first isolated and characterized human bone marrow-derived MSCs, and then assessed the impact of their secretome on BC cells. Treatment with the MSC-derived secretome significantly inhibited the proliferation and migration of both MDA-MB-231 and MCF-7 BC cell lines, resulting in reduced cell viability and migration rates compared to control cells. Western blot analyses revealed downregulation of Cyclin D1 and c-Myc, along with decreased expression of N-cadherin and increased expression of E-cadherin, indicating potential inhibition of the epithelial-to-mesenchymal transition. Differential gene expression analyses highlighted TET1 as significantly upregulated inTNBC tissues compared to normal samples. Further experiments confirmed that the MSC-derived secretome downregulated TET1 expression in BC cells, as evidenced by RT-qPCR and western blot analyses. To explore TET1’s functional role, we silenced TET1 with siRNAs, observing cell cycle arrest and enhanced apoptosis—effects that mirrored those seen with MSC-secretome treatment. Notably, TET1 knockdown also increased MDA-MB-231 cell sensitivity to cisplatin, suggesting a role forTET1 in chemoresistance. These findings provide insight into the ability of MSCs to modulate BC cell progression through their secretome, highlighting the involvement ofTET1 downregulation in inhibiting BC cell progression and enhancing cisplatin chemosensitivity. The MSC-derived secretome thus holds promise as an innovative, cell-free therapeutic approach in BC treatment.  \nKeywords Mesenchymal stem cells, Secretome, Breast cancer, TET1  \nUnderstanding the role of the unique tumor microenvironment (TME) in the progression of triple-negative breast cancer (TNBC) is a complex process. This complexity arises from the dynamic and ever-changing nature of the microenvironment, which comprises various components, including fibroblasts, immune-suppressive cells, and soluble factors1–4. The rapid proliferation of tumor cells in TNBC results in hypoxia, which in turn leads to the reprogramming of tumor cells within the TME5. Tumor cells and the TME continuously adapt to changing conditions, and the dynamic interactions between them significantly influence tumor development and growth. A substantial body of research has demonstrated that different molecular subtypes of TNBC, the most common form of invasive breast cancer, exhibit distinct TME patterns6. While alterations in genetic material are the primary drivers of BC development, the TME plays a crucial role in its progression7.  \nMesenchymal stem cells (MSCs) represent a burgeoning area of research focused on their role in maintaining tissue homeostasis and regenerating damaged tissues8–10. MSCs are increasingly recognized for their dual and complex role in cancer, possessing the potential to both inhibit and promote tumor progression. In response  \n1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, P.O. Box: 14115-  \n154, Tehran, Iran. 2Department of Biomedical Engineering, University of North Texas, Denton, TX, USA. 3Romina Motamed and Keyvan Jabbari contributed e","cbCaiexGWNZm21Qg","https://ap.wps.com/l/cbCaiexGWNZm21Qg","pdf",3362372,12,"English","# Abstract\n## Background: MSC secretome in the tumor microenvironment\n## Role of TET1 and DNA methylation in TNBC\n## Experimental findings: effects on cell behavior\n## Mechanistic validation: TET1 silencing and chemosensitivity","[{\"question\":\"How does the MSC-derived secretome affect breast cancer cell growth and movement?\",\"answer\":\"Treatment with MSC-derived secretome significantly inhibits proliferation and migration of MDA-MB-231 and MCF-7 breast cancer cell lines, reducing viability and migration rates versus control cells.\"},{\"question\":\"What molecular changes indicate inhibition of epithelial-to-mesenchymal transition?\",\"answer\":\"Western blot analyses show downregulation of Cyclin D1 and c-Myc, decreased N-cadherin, and increased E-cadherin, consistent with potential suppression of epithelial-to-mesenchymal transition.\"},{\"question\":\"How is TET1 linked to chemoresistance and how do researchers test it?\",\"answer\":\"TET1 is upregulated in TNBC tissues, and MSC-derived secretome downregulates TET1 in breast cancer cells. Silencing TET1 with siRNAs causes cell cycle arrest and enhanced apoptosis and increases MDA-MB-231 sensitivity to cisplatin, indicating a role in chemoresistance.\"}]","Mesenchymal stem cells modulate breast cancer progression through their secretome by downregulating ten-eleven translocation 1 - Research Findings on TET1 Inhibition | PDF",1790181401,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4b76e27b9cd4c0dff4d81ab35477e56.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effd9781c7dcb1b477d21f4156b05b3d.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fcc4df29d1ba4d0beab3e96d75be5f3.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e05938858e89c2209b8cda6b6b53429.webp",980,1287]